Multicenter, Randomized Study Comparing Oral Valganciclovir Versus Intravenous Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation.

Trial Profile

Multicenter, Randomized Study Comparing Oral Valganciclovir Versus Intravenous Ganciclovir in Patients Following Allogeneic Stem Cell Transplantation.

Discontinued
Phase of Trial: Phase III

Latest Information Update: 16 Dec 2013

At a glance

  • Drugs Valganciclovir (Primary) ; Ganciclovir
  • Indications Cytomegalovirus infections
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms CONVINCE
  • Most Recent Events

    • 31 Mar 2012 Inclusion and exclusion criteria amended as reported by European Clinical Trials Database record.
    • 23 Mar 2012 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
    • 14 Jun 2011 Additional locations (Austria,Germany, Spain) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top